Opportunity Overview
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies for analyzing, targeting, probing, handling, or quality control of biospecimens used in cancer research or clinical care. The emphasis of this NOFO is on early-stage projects proposing proof-of-concept/pilot studies to test the feasibility of the proposed method, tool, assay, platform, or instrument. Well-suited applications must offer a high degree of technical innovation and the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, cancer control, epidemiology, and/or address issues associated with cancer health disparities. Technologies proposed for development may have potential for widespread applicability but must be focused in this proposal on cancer applications. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
How to bid: GlobalGov tracks this tender; it does not accept bids. Submit your response through the issuing agency’s official notice.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start a free GlobalGov accountSolicitation Details
| Issuing agency | National Institutes of Health |
|---|---|
| Country | United States |
| Category | Laboratory Services |
| Estimated value | $5.1M |
| Published | June 03, 2026 |
| Procurement stage | Request for Proposal (RFP) |
| Response due | November 10, 2026 |
| Status | Open — accepting responses |
| Official source | View original notice |
| Last verified | October 11, 2026 |
Source: U.S. Government (Simpler.Grants.gov) — public domain. Not affiliated with or endorsed by the United States Government.
Related Opportunities in United States
Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)
See every United States Laboratory Services opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United States Laboratory Services intelligence report in your inbox
A personalized report on United States Laboratory Services opportunities, emailed in 5-10 minutes. One per month, no account needed.